{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:45:36Z","timestamp":1759938336367,"version":"3.37.3"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2014R1A1A1002431"],"award-info":[{"award-number":["2014R1A1A1002431"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0200509","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T14:23:04Z","timestamp":1531318984000},"page":"e0200509","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of pemetrexed and etoposide as therapeutic regimens for human papillomavirus-positive oral and oropharyngeal cancer"],"prefix":"10.1371","volume":"13","author":[{"given":"Yi Rang","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bada","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Ran","family":"Byun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Kil","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1177-598X","authenticated-orcid":true,"given":"Jin Woo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study","volume":"3","author":"C Fitzmaurice","year":"2017","journal-title":"JAMA oncology"},{"issue":"1","key":"ref2","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"RL Siegel","year":"2017","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/aje\/kwt029","article-title":"Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium","volume":"178","author":"A Wyss","year":"2013","journal-title":"American journal of epidemiology"},{"issue":"19","key":"ref4","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJM198205133061905","article-title":"Risk factors in head and neck cancer","volume":"306","author":"J Decker","year":"1982","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.oraloncology.2011.10.007","article-title":"Involvement of viral factors with head and neck cancers","volume":"48","author":"SM Gondivkar","journal-title":"Oral Oncology"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.6004\/jnccn.2011.0055","article-title":"The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms?","volume":"9","author":"EM Sturgis","year":"2011","journal-title":"Journal of the National Comprehensive Cancer Network"},{"issue":"5","key":"ref7","first-page":"401","article-title":"Oral cavity and oropharyngeal squamous cell carcinoma\u2014an update","volume":"65","author":"AC Chi","year":"2015","journal-title":"CA: a cancer journal for clinicians"},{"issue":"32","key":"ref8","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"AK Chaturvedi","year":"2011","journal-title":"Journal of clinical oncology"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1470-2045(15)00560-4","article-title":"Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study","volume":"17","author":"B O'Sullivan","year":"2016","journal-title":"The Lancet Oncology"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.oraloncology.2013.12.019","article-title":"Epidemiology of HPV-associated oropharyngeal cancer","volume":"50","author":"KB Pytynia","year":"2014","journal-title":"Oral oncology"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S1470-2045(14)70471-1","article-title":"HPV DNA, E6\/E7 mRNA, and p16 INK4a detection in head and neck cancers: a systematic review and meta-analysis","volume":"15","author":"C Ndiaye","year":"2014","journal-title":"The Lancet Oncology"},{"issue":"15","key":"ref12","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJM200104123441503","article-title":"Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck","volume":"344","author":"J Mork","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","article-title":"Evidence for a causal association between human papillomavirus and a subset of head and neck cancers","volume":"92","author":"ML Gillison","year":"2000","journal-title":"Journal of the National Cancer Institute"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMra0707975","article-title":"Recent advances in head and neck cancer","volume":"359","author":"RI Haddad","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"375","key":"ref15","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"2016","author":"RL Ferris","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.6004\/jnccn.2017.0101","article-title":"NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017","volume":"15","author":"D Adelstein","year":"2017","journal-title":"Journal of the National Comprehensive Cancer Network"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved Survival of Patients With Human Papillomavirus\u2013Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial","volume":"100","author":"C Fakhry","year":"2008","journal-title":"JNCI: Journal of the National Cancer Institute"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","article-title":"HPV-associated head and neck cancer: a virus-related cancer epidemic","volume":"11","author":"S Marur","year":"2010","journal-title":"The Lancet Oncology"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1758-3284-2-15","article-title":"Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)","volume":"2","author":"F Dayyani","year":"2010","journal-title":"Head & Neck Oncology"},{"key":"ref20","article-title":"Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery","author":"MA Broglie","year":"2017","journal-title":"Head & Neck"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ejca.2006.09.001","article-title":"Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas","volume":"43","author":"I Martinez","year":"2007","journal-title":"European journal of cancer"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/sj.onc.1205214","article-title":"Involvement of intact HPV16 E6\/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control","volume":"21","author":"T Wiest","year":"2002","journal-title":"Oncogene"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"JB Vermorken","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"ref24","first-page":"471","article-title":"Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck","volume":"66","author":"J Kish","year":"1982","journal-title":"Cancer treatment reports"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00280-003-0625-9","article-title":"Thymidylate synthase inhibitors as anticancer agents: from bench to bedside","volume":"52","author":"E Chu","year":"2003","journal-title":"Cancer chemotherapy and pharmacology"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2174\/1568011054222364","article-title":"Etoposide, topoisomerase II and cancer","volume":"5","author":"E Baldwin","year":"2005","journal-title":"Current Medicinal Chemistry-Anti-Cancer Agents"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1200\/JCO.2016.68.3300","article-title":"E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx\u2014ECOG-ACRIN Cancer Research Group","volume":"35","author":"S Marur","year":"2016","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1470-2045(16)30066-3","article-title":"Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial","volume":"17","author":"TY Seiwert","year":"2016","journal-title":"The lancet oncology"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/00016480600801381","article-title":"Thymidine phosphorylase mRNA level predicts survival of patients with advanced oropharyngeal cancer","volume":"127","author":"T Ijuin","year":"2007","journal-title":"Acta oto-laryngologica"},{"issue":"21","key":"ref30","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non\u2013small-cell lung cancer","volume":"26","author":"GV Scagliotti","year":"2008","journal-title":"Journal of clinical oncology"},{"issue":"19","key":"ref31","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1002\/cncr.27449","article-title":"Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer","volume":"118","author":"S Urba","year":"2012","journal-title":"Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fonc.2014.00362","article-title":"Carboplatin-pemetrexed in treatment of patients with recurrent\/metastatic cancers of the head and neck; superior outcomes in oropharyngeal primaries","volume":"4","author":"B Malhotra","year":"2015","journal-title":"Frontiers in oncology"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/cncr.25464","article-title":"A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer","volume":"117","author":"MG Fury","year":"2011","journal-title":"Cancer"},{"issue":"5","key":"ref34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1054\/bjoc.2001.2010","article-title":"Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck","volume":"85","author":"X Pivot","year":"2001","journal-title":"British journal of cancer"},{"issue":"9","key":"ref35","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1200\/JCO.2010.33.3591","article-title":"Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer","volume":"29","author":"A Argiris","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"13","key":"ref36","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.ejca.2013.05.002","article-title":"Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck","volume":"49","author":"J Vermorken","year":"2013","journal-title":"European Journal of Cancer"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1748-717X-8-40","article-title":"Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma-GORTEC 2004\u201302","volume":"8","author":"Y Tao","year":"2013","journal-title":"Radiation Oncology"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/07357900600633734","article-title":"Salvage therapy with oral etoposide in recurrent and\/or metastatic squamous cell carcinoma of the head and neck","volume":"24","author":"C Gedlicka","year":"2006","journal-title":"Cancer investigation"},{"article-title":"Seminars in oncology","year":"1992","author":"D Osoba","key":"ref39"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0200509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T21:44:00Z","timestamp":1540244640000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0200509"}},"subtitle":[],"editor":[{"given":"Muy-Teck","family":"Teh","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,7,11]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0200509","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,7,11]]}}}